https://www.taxtmi.com/caselaws?id=755639 The SC upheld the Delhi HC's decision allowing the National Pharmaceutical Pricing Authority to recover excess amounts charged by appellant for Roscilox drug above government-fixed prices under Drugs (Price Control) Order, 1995. Appellant claimed it was only a dealer, not a distributor/manufacturer/importer subject to Paragraph 13 of DPCO. However, appellant's own admissions showed direct purchase from manufacturer, indicating distributor status. Given overlapping definitions in DPCO and appellant's inconsistent versions without proper documentation, the court found no error in rejecting appellant's claim. Appeal dismissed. en-us Mon, 15 Jul 2024 00:00:00 +0530 Wed, 17 Jul 2024 08:04:45 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=755639 The SC upheld the Delhi HC's decision allowing the National Pharmaceutical Pricing Authority to recover excess amounts charged by appellant for Roscilox drug above government-fixed prices under Drugs (Price Control) Order, 1995. Appellant claimed it was only a dealer, not a distributor/manufacturer/importer subject to Paragraph 13 of DPCO. However, appellant's own admissions showed direct purchase from manufacturer, indicating distributor status. Given overlapping definitions in DPCO and appellant's inconsistent versions without proper documentation, the court found no error in rejecting appellant's claim. Appeal dismissed. Case-Laws Indian Laws Mon, 15 Jul 2024 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=755639